Search Results
Found 1 results
510(k) Data Aggregation
(24 days)
The OPUS Myoglobin Controls are intended for use as quality control material to monitor the precision and accuracy of the OPUS Mvoqlobin assay.
The OPUS Myoglobin Controls are lyophilized controls containing known levels of human myoglobin in processed human serum. The control is provided at three levels (low, mid and high). The OPUS Myoglobin Control is only for use with the OPUS Myoglobin assay and has not been evaluated for use with other assays.
The provided text describes a 510(k) summary for "OPUS Myoglobin Controls," which are quality control materials. It does not describe a study involving a diagnostic device that detects or diagnoses a condition, nor does it present acceptance criteria and performance data in the typical sense of a diagnostic accuracy study.
Therefore, many of the requested elements (like sample size for test set, data provenance, number of experts, adjudication methods, MRMC studies, standalone performance, training set details) are not applicable to this type of submission for quality control materials.
However, I can extract the closest analogous information regarding "acceptance criteria" (implied performance expectations for a QC material) and "device performance" (results of the precision study).
Here's the breakdown based on the provided text:
1. A table of acceptance criteria and the reported device performance
| Acceptance Criteria (Implied) | Reported Device Performance |
|---|---|
| Intra-assay Precision: Not explicitly stated, but generally, acceptable CVs for QC materials in immunoassays are typically low (e.g., < 10% or < 15%) | Intra-assay Precision (n=20): %CVs ranged from 4.27% to 6.05% for myoglobin. |
| Inter-assay Precision: Not explicitly stated, but generally, acceptable CVs for QC materials in immunoassays are typically low to moderate (e.g., < 15% or < 20%) | Inter-assay Precision (n=8): %CVs ranged from 6.55% to 10.54% for myoglobin. |
Explanation of "Implied" Acceptance Criteria: The document describes the results of the precision studies but does not explicitly state pre-defined acceptance criteria (e.g., "The intra-assay %CV must be less than X%"). However, the reported CVs (4.27% to 10.54%) are generally considered good for immunoassay quality control materials, implying they met the manufacturer's internal performance expectations for precision.
Regarding the other requested points:
- 2. Sample sized used for the test set and the data provenance:
- Test Set Sample Size: For intra-assay precision, n=20 for each control level. For inter-assay precision, n=8 (duplicate determinations run twice over 15 days).
- Data Provenance: Not explicitly stated, but implied to be from Behring Diagnostics, Inc. (manufacturer) in Westwood, MA, USA. This would be prospective testing conducted by the manufacturer.
- 3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts: Not applicable. This device is a quality control material, not a diagnostic device requiring expert interpretation for ground truth.
- 4. Adjudication method for the test set: Not applicable. See point 3.
- 5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance: Not applicable. This is not an AI-assisted diagnostic device.
- 6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done: Not applicable. This is not an algorithmic diagnostic device.
- 7. The type of ground truth used (expert consensus, pathology, outcomes data, etc): Not applicable. For quality control materials, the "ground truth" is the known concentration of the analyte (myoglobin in this case) added to the control, which is then measured by the assay.
- 8. The sample size for the training set: Not applicable. This is not a machine learning or AI device.
- 9. How the ground truth for the training set was established: Not applicable. See point 8.
Ask a specific question about this device
Page 1 of 1